NEKTAR THERAPEUTICS (NKTR) › Total AssetsNEKTAR THERAPEUTICS (NKTR) — Total AssetsAnnual figures by fiscal year, from SEC filings.2010: $521.23M2011: $606.55M2012: $497.79M2013: $434.53M2014: $441.62M2015: $498.64M2016: $568.87M2017: $508.87M2018: $2.15B2019: $1.98B2020: $1.54B2021: $1.12B2022: $710.60M2023: $398.03M2024: $303.85M2025: $280.41M$280.41M2010Total Assets (USD)2025Fiscal YearTotal AssetsChange YoY2025$280.41M-7.7%2024$303.85M-23.7%2023$398.03M-44.0%2022$710.60M-36.4%2021$1.12B-27.4%2020$1.54B-22.2%2019$1.98B-8.0%2018$2.15B+322.5%2017$508.87M-10.5%2016$568.87M+14.1%2015$498.64M+12.9%2014$441.62M+1.6%2013$434.53M-12.7%2012$497.79M-17.9%2011$606.55M+16.4%2010$521.23M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share